Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice

Cancer Research

Volumn 59, Issue 15, 1999, Pages 3698-3704

  Tartour, Eric ^a,b   Fossiez, François ^c   Joyeux, Isabelle ^a   Galinha, Annie ^a   Gey, Alain ^a   Claret, Emmanuel ^d   Sastre Garau, Xavier ^b   Couturier, Jérôme ^b   Mosseri, Veronique ^b   Vives, Virginie ^a   Banchereau, Jacques ^c   Fridman, Wolf H ^a   Wijdenes, John ^d   Lebecque, Serge ^c   Sautès Fridman, Catherine ^a  

^a INSERM   (France)

^b INSTITUT CURIE   (France)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Diaclone   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CARCINOGENICITY; CELL PROLIFERATION; CYTOKINE RELEASE; GENETIC TRANSFECTION; HELPER CELL; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; T LYMPHOCYTE; UTERINE CERVIX TUMOR;

ANIMALS; CARCINOGENS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MELANOMA; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSFECTION; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 17444401702     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Rouvier, E., Luciani, M. F., Mattei, M. G., Denizot, F., and Golstein, P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol., 150: 5445-5556, 1993.
2. Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., Blanchard, D., Gaillard, C., Das Mahapatra, B., Rouvier, E., Golstein, P., Banchereau, J., and Lebecque, S. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med., 183: 2593-2603, 1996.
3. Spriggs, M. K. Interleukin-17 and its receptor. J. Clin. Immunol., 17: 366-369, 1997.
4. Fleckenstein, B., and Desrosiers, R. C. Herpesvirus saimiri and Herpesvirus ateles. In: I. B. Roizman (ed.), The Herpesviruses, pp 253-332. New York: Plenum Publishing Press, 1992.
5. Mittrucker, H. W., Muller-Fleckenstein, I., Fleckenstein, B., and Fleischer, B. CD2-mediated autocrine growth of Herpesvirus saimiri-transformed human T lymphocytes. J. Exp. Med., 176: 909-913, 1992.
6. Biesinger, B., Muller-Fleckenstein, I., Simmer, B., Lang, G., Wittmann, S., Platzer, E., Desrosiers, R. C., and Fleckenstein, B. Stable growth transformation of human T lymphocytes by Herpesvirus saimiri. Proc. Natl. Acad. Sci. USA, 89: 3116-3119, 1992.
7. Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A. M., Painter, S. L., Comeau, M. R., Cohen, J. I., and Spriggs, M. K. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity, 3: 811-821, 1995.
8. Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jollcoeur, F. C., He, Y., Mineau, F., and Pelletier, J. P. IL-17 stimulates the production and expression of proinflammatory cytokines, IL1-β and TNF-α, by human macrophages. J. Immunol., 160: 3513-3521, 1998.
9. Teunissen, M. B., Koomen, C. W., de Waal Malefyt, R., Wierenga, E. A., and Bos, J, D. Interleukin-17 and interferon-γ synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Investig. Dermatol., 111: 645-649, 1998.
10. Chabaud, M., Fossiez, F., Taupin, J. L., and Miossec, P. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J. Immunol., 161: 409-414, 1998.
11. Shalom-Barak, T., Quach, J., and Lotz, M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB. J. Biol. Chem., 273: 27467-27473, 1998.
12. Attur, M. G., Patel, R. N., Abramson, S. B., and Amin, A. R. Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum., 40: 1050-1053, 1997.
13. Fridman, W. H., and Tartour, E. Cytokines and cell regulation. In: Molecular Aspects of Medicine, pp. 3-90. Oxford, United Kingdom: Elsevier Science, 1997.
14. Vink, A., Coulie, P., Warnier, G., Renauld, J. C., Stevens, M., Donckers, D., and Van Snick, J. Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor. J. Exp. Med., 172: 997-1000, 1990.
15. Scala, G., Quinto, I., Ruocco, M. R., Arcucci, A., Mallardo, M., Caretto, P., Forni, G., and Venuta, S. Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity. J. Exp. Med., 172: 61-68, 1990.
16. Durandy, A., Emilie, D., Peuchmaur, M., Forveille, M., Clement, C., Wijdenes, J., and Fischer, A. Role of IL-6 in promoting growth of human EBV-induced B-cell tumors in severe combined immunodeficient mice. J. Immunol., 152: 5361-5367, 1994.
17. Bataille, R., Barlogie, B., Lu, Z. Y., Rossi, J. F., Lavabre-Bertrand, T., Beck, T., Wijdenes, J., Brochier, J., and Klein, B. Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood, 86: 685-691, 1995.
18. Schadendorf, D., Moller, A., Algermissen, B., Worm, M., Sticherling, M., and Czarnetzki, B. M. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol., 151: 2667-2675, 1993.
19. Singh, R. K., Gutman, M., Radinsky, R., Bucana, C. D., and Fidler, I. J. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res., 54: 3242-3247, 1994.
20. Schiffmank, M. H., and Brinton, L. A. The epidemiology of cervical carcinogenesis. Cancer (Phila.), 76 (Suppl. 10): 1888-1901, 1995.
21. Iglesias, M., Plowman, G. D., and Woodworth, C. D. Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitro. Am. J. Pathol., 146: 944-952, 1995.
22. Eustace, D., Han, X., Gooding, R., Rowbottom, A., Riches, P., and Heyderman, E. Interleukin-6 (EL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Gynecol. Oncol., 50: 15-19, 1993.
23. Woodworth, C. D., and Simpson, S. Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines. Am. J. Pathol., 142: 1544-1555, 1993.
24. Tartour, E., Gey, A., Sastre-Garau, X., Pannetier, C., Mosseri, V., Kourilsky, P., and Fridman, W. H. Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. Cancer Res., 54: 6243-6248, 1994.
25. Couturier, J., Sastre-Garau, X., Schneider-Maunoury, S., Labib, A., and Orth, G. Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression. J. Virol., 65: 4534-4538, 1991.
26. Montera, F., Brailly, H., Sautès, C., Joyeux, I., Dorval, T., Mosseri, V., Yasukawa, K., Wijdenes, J., Adler, A., Gorin, I., Fridman, W. H., and Tartour, E. Characterization of soluble gp130 released by melanoma cell lines: a polyvalent antagonist of cytokines from IL6 family. Clin. Cancer Res., 3: 1443-1451, 1997.
27. Daeron, M., Latour, S., Malbec, O., Espinosa, E., Pina, P., Pasmans, S., and Fridman, W. H. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc γ RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity, 3: 635-646, 1995.
28. Tartour, E., Gey, A., Sastre-Garau, X., Lombard Surin, I., Mosseri, V., and Fridman, W. H. Prognostic value of intratumoral interferon γ messenger RNA expression in invasive cervical carcinoma. J. Natl. Cancer Inst., 4: 287-294, 1998.
29. Hansen, M. B., Nielsen, S. E., and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119: 203-210, 1989.
30. Cai, X. Y., Gommoll, C. P., Jr., Justice, L., Narula, S. K., and Fine, J. S. Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17. Immunol. Lett., 62: 51-58, 1998.
31. Kennedy, J., Rossi, D. L., Zurawski, S. M., Vega, F., Jr., Kastelein, R. A., Wagner, J. L., Hannum, C. H., and Zlotnik, A. Mouse IL-17: a cytokine preferentially expressed by α β TCR + CD4-CD8-T cells. J. Interferon Cytokine Res., 16: 611-617, 1996.
32. Sun, W. H., Kreisle, R. A., Phillips, A. W., and Ershler, W. B. In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells. Cancer Res., 52: 5412-5415, 1992.
33. Mullen, C. A., Coale, M. M., Levy, A. T., Stetler-Stevenson, W. G., Liotta, L. A., Brandt, S., and Blaese, R. M. Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential. Cancer Res., 52: 6020-6024, 1992.
34. Lu, C., Sheehan, C., Rak, J. W., Chambers, C. A., Hozumi, N., and Kerbel, R. S. Endogenous interleukin 6 can function as an in vivo growth-stimulatory factor for advanced-stage human melanoma cells. Clin. Cancer Res., 2: 1417-1425, 1996.
35. Nowicki, A., Szenajch, J., Ostrowska, G., Wojtowicz, A., Wojtowicz, K., Kruszewski, A. A., Maruszynski, M., Aukerman, S. L., and Wiktor-Jedrzejczak, W. Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. Int. J. Cancer, 65: 112-119, 1996.
36. Richter, G., Kruger-Krasagakes, S., Hein, G., Huls, C., Schmitt, E., Diamantstein, T., and Blankenstein, T. Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res., 53: 4134-4137, 1993.
37. Van Kooten, C., Boonstra, J. G., Paape, M. E., Fossiez, F., Banchereau, J., Lebecque, S., Bruijn, J. A., De Fijter, J. W., Van Es, L. A., and Daha, M. R. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J. Am. Soc. Nephrol., 9: 1526-1534, 1998.
38. Schwarzenberger, P., La Russa, V., Miller, A., Ye, P., Huang, W., Zieske, A., Nelson, S., Bagby, G. J., Stoltz, D., Mynatt, R. L., Spriggs, M., and Rolls, J. K. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol., 161: 6383-6389, 1998.
39. Freeman, M. R., Schneck, F. X., Gagnon, M. L., Corless, C., Soker, S., Niknejad, K., Peoples, G. E., and Klagsbrun, M. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res., 55: 4140-4145, 1995.
40. Blotnick, S., Peoples, G. E., Freeman, M. R., Eberlein, T. J., and Klagsbrun, M. T. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. Proc. Natl. Acad. Sci. USA, 91: 2890-2894, 1994.
41. Miyoshi, E., Higashiyama, S., Nakagawa, T., Hayashi, N., and Taniguchi, N. Membrane-anchored heparin-binding epidermal growth factor-like growth factor acts as a tumor survival factor in a hepatoma cell line. J. Biol. Chem., 272: 14349-14355, 1997.
42. Kaido, T. J., Maury, C., and Gresser, I. Host CD4+ T lymphocytes are required for the synergistic action of interferon-α/β and adoptively transferred immune cells in the inhibition of visceral ESb metastases. Cancer Res., 55: 6133-6139, 1995.
43. Hock, H., Dorsch, M., Diamantstein, T., and Blankenstein, T. Interleukin 7 induces CD4+ T cell-dependent tumor rejection. J. Exp. Med., 174: 1291-1298, 1991.
44. Flamand, V., Biernaux, C., Van Mechelen, M., Sornasse, T., Urbain, J., Leo, O., and Moser, M. Immune surveillance: both CD3+ CD4+ and CD3+ CD8+ T cells control in vivo growth of P815 mastocytoma. Int. J. Cancer, 45: 757-762, 1990.
45. North, R. J. Down-regulation of the antitumor immune response. Adv. Cancer Res., 45: 1-43, 1985.
46. Katz, I. R., Chapman-Alexander, J., Jacobson, E. B., Lerman, S. P., and Thorbecke, G. J. Growth of SJL/J-derived transplantable reticulum cell sarcoma as related to its ability to induce T-cell proliferation in the host. III. Studies on thymectomized and congenially athymic SJL mice. Cell. Immunol., 65: 84-92, 1981.
47. Ohnishi, K., and Bonavida, B. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation. J. Immunol., 138: 4524-4529, 1987.
48. Ohnishi, K., and Bonavida, B. Regulation of B-cell lymphoma growth in syngeneic SJL/J mice. Establishment of tumor dormancy following administration of anti-CD4 monoclonal antibody into tumor-bearing mice. Leukemia (Baltimore), 7: 1801-1806, 1993.
49. Rakhmilevich, A. L., and North, R. J. Elimination of CD4+ T cells in mice bearing an advanced sarcoma augments the antitumor action of interleukin-2. Cancer Immunol. Immunother., 38: 107-112, 1994.
50. Colombo, M. P., Vagliani, M., Spreafico, F., Parenza, M., Chiodoni, C., Melani, C., and Stoppacciaro, A. Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res., 56: 2531-2534, 1996.
51. Martinotti, A., Stoppacciaro, A., Vagliani, M., Melani, C., Spreafico, F., Wysocka, M., Parmiani, G., Trinchieri, G., and Colombo, M. P. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Eur. J. Immunol., 25: 137-146, 1995.
52. Mandelboim, O., Vadai, E., Fridkin, M., Katz-Hillel, A., Feldman, M., Berke, G., and Eisenbach, L. Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides. Nat. Med., 1: 1179-1183, 1995.
53. Nakamura, S., Salahuddin, S. Z., Biberfeld, P., Ensoli, B., Markham, P. D., Wong-Staal, F., and Gallo, R. C. Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. Science (Washington DC), 242: 426-430, 1988.
54. Umetsu, D. T., Esserman, L., Donlon, T. A., DeKruyff, R. H., and Levy, R. Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J. Immunol., 144: 2550-2557, 1990.
55. 0) breast carcinoma. J. Clin. Oncol., 7: 355-366, 1989.